We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLRN
951
DELISTED
Acceleron Pharma
XLRN
$2.58M 0.02%
20,565
+516
+3% +$65.1K
SFM icon
952
Sprouts Farmers Market
SFM
$8.16B
$2.58M 0.02%
103,766
-42,924
-29% -$1.15M
WORK
953
DELISTED
Slack Technologies, Inc.
WORK
$2.58M 0.02%
58,189
+3,793
+7% +$162K
UBSI icon
954
United Bankshares
UBSI
$6.63B
$2.58M 0.02%
70,604
-4,370
-6% -$172K
MOH icon
955
Molina Healthcare
MOH
$10.2B
$2.58M 0.02%
10,174
+1,612
+19% +$405K
CNR
956
Core Natural Resources Inc
CNR
$4.38B
$2.57M 0.02%
139,014
+55,884
+67% +$751K
CHNG
957
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$2.56M 0.02%
110,931
+12,638
+13% +$291K
GDO
958
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
$2.55M 0.02%
137,172
+3,115
+2% +$56.2K
IOVA icon
959
Iovance Biotherapeutics
IOVA
$2.72B
$2.55M 0.02%
98,060
+8,638
+10% +$225K
PDT
960
John Hancock Premium Dividend Fund
PDT
$625M
$2.55M 0.02%
150,455
+60,018
+66% +$975K
DSL
961
DoubleLine Income Solutions Fund
DSL
$1.24B
$2.52M 0.01%
139,525
-6,142
-4% -$111K
GEN icon
962
Gen Digital
GEN
$17.5B
$2.52M 0.01%
92,721
+13,480
+17% +$336K
MGLN
963
DELISTED
Magellan Health Services, Inc.
MGLN
$2.52M 0.01%
26,752
+8,797
+49% +$829K
EQH icon
964
Equitable Holdings
EQH
$14.1B
$2.51M 0.01%
82,526
+62,852
+319% +$2.05M
FL
965
DELISTED
Foot Locker
FL
$2.51M 0.01%
40,750
-7,822
-16% -$473K
HPF
966
John Hancock Preferred Income Fund II
HPF
$344M
$2.5M 0.01%
115,971
+30,107
+35% +$638K
ENTG icon
967
Entegris
ENTG
$23B
$2.5M 0.01%
20,356
-1,432
-7% -$165K
ETO
968
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$519M
$2.49M 0.01%
85,040
-56,389
-40% -$1.62M
GT icon
969
Goodyear
GT
$1.88B
$2.49M 0.01%
144,983
-41,562
-22% -$766K
AZTA icon
970
Azenta
AZTA
$1.45B
$2.48M 0.01%
26,028
-11,894
-31% -$1.15M
TPH
971
DELISTED
Tri Pointe Homes
TPH
$2.48M 0.01%
115,551
-3,348
-3% -$76.7K
NUAN
972
DELISTED
Nuance Communications, Inc.
NUAN
$2.47M 0.01%
45,431
+35,518
+358% +$1.87M
HLF icon
973
Herbalife
HLF
$1.26B
$2.47M 0.01%
46,879
+24,103
+106% +$1.2M
SBAC icon
974
SBA Communications
SBAC
$19.5B
$2.47M 0.01%
7,753
+108
+1% +$32.4K
EXPE icon
975
Expedia Group
EXPE
$37.2B
$2.47M 0.01%
15,063
+3,452
+30% +$592K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.